MabPlex provides world-class solutions to biopharmaceutical clients around the world. Our company is based on the quality by design (QbD) principle, from site construction to manufacturing and delivery of our clients’ biologic drugs. With an expert team adept in both chemistry and biology, MabPlex provides global contract development and manufacturing organization (CDMO) services in biopharmaceuticals. Capabilities span the scope from monoclonal antibodies (MAbs) and fusion proteins to the most complicated antibody–drug conjugates (ADCs). Our 275,000-ft² manufacturing space offers flexibility and complete services from upstream cell line development to manufacturing and fill–finish of commercial products. Our technical expertise allows us to provide effective high-quality solutions for your biomanufacturing needs. With that, MabPlex delivers our commitment to you through our quality manufacturing, meeting your expectations.
Login to read the full PDF of the application note.